The binding of oleic acid to human serum albumin causes progressive changes in (a) the pK of some amino acid residues, as detected by pH-stat titration and (b) the induced molar ellipticities of albumin-bound drugs (diazepam and oxyphenbutazone), as measured by c.d. It is concluded that albumin undergoes several conformational transitions as the amount of oleic acid bound increases from 0 to about 9 molecules/ molecule of protein. At least three different conformations of the protein seem to be involved. These conformations can be linked with the three classes of oleic acid-binding sites on albumin.
INTRODUCTION
The binding of drugs to human serum albumin (HSA) continues to be a widely studied phenomenon (Vallner, 1977; Kragh-Hansen, 1981) . Research carried out during the last few years has revealed the enormous complexity of the problem. The complexity is due to a number of factors.
(1) Albumin has two specific binding sites, the diazepam-and the warfarin-binding site (Sudlow et al., 1976; Brodersen et al., 1977; Fehske et al., 1979 Fehske et al., , 1981 Sjoholm et al., 1979) , also called 'site II' and 'site I' repectively.
(2) Ligands can bind to albumin in a ratio higher than 1. This implies the existence of both low-affinity and high-affinity sites.
(3) In albumin, conformational changes occur. Of these conformational changes, the proton-linked N-B transition (which has been demonstrated to occur in the pH region 6-9) (Leonard et al., 1963; Harmsen et al., 1971 ) is important for studies on binding at about physiological pH, because the affinity of drugs for either the N or the B conformation may be different (Wilting et al., 1980a) .
(4) Simple ions, such as Cl-and Ca2l, influence drug binding (Wilting et al., 1980a . This influence may be either direct (displacement) or indirect (allosteric). Fatty acids or other bound drugs can give rise to similar effects [see Droge et al. (1985) and references cited therein].
This combination of factors means that a measured ligand-binding constant (and any quantity related to it, such as free concentration) for any substance binding to albumin is an apparent one, that is to say, it is a function of the above-mentioned parameters. In other words, such a binding constant will be a function of the free concentration (or, better, the activity) of all the species involved in the binding (Wyman, 1964 Several steps in Scheme 1 have been studied. Reaction 1 was studied by measuring both the free concentration of warfarin (Wilting et al., 1980a) and diazepam (Wilting et al., 1980b) and AZ1 as a function of pH . Reaction 4 has also been studied recently by measuring the free concentration of drug as a function of the ratio of F and as a function of pH (Droge et al., 1985) . In (Fehske et al., 1981) and a site-II drug (diazepam) (Sudlow et al., 1976; Brodersen et al., 1977; Fehske et al., 1979 Fehske et al., , 1981 are used as a label.
EXPERIMENTAL HSA (infusion solution) was a gift from the BiotestSerum-Institut G.m.b.H., Frankfurt am Main, Germany.
We gave the batch lot no. 820512. The albumin was deionized before use and its concentration determined as described elsewhere (Droge et al., 1982) . The deionizing procedure yielded a protein solution in which 0.9 mol of fatty acid is bound/mol of albumin. The method of measurement has been described previously (Dr6ge et al., 1982) . We used this albumin sample with 0.9 mol of fatty acid/mol of albumin as our starting material because we thought it might be advisable to work with albumin that contains some bound fatty acid (Droge et al., 1982) . This value of 0.9 is included in those quoted in the present paper and also in the Figures shown. The identity of these fatty acids is not known. However, in order to avoid complicated formulations, it is assumed here that these residual fatty acids are oleic acid molecules.
Diazepam (7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one; a gift from HoffmanLa Roche, Mijdrecht, The Netherlands), oxyphenbutazone [4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione], a gift from Ciba-Geigy BV (Arnhem, The Netherlands), '4C-labelled diazepam (2.11 GBq * mmol-P; Amersham Nederland BV, Utrecht, The Netherlands), "4C-labelled oxyphenbutazone (1.14GBq mmol1-; New England Nuclear, Boston, MA, U.S.A.) and oleic acid (sodium salt; Sigma Chemical Co., St. Louis, MO, U.S.A.) were used without further purification. All other chemicals were of analytical grade (Merck, Darmstadt, Germany, or J. T. Baker, Deventer, The Netherlands).
The affinity of diazepam and oxyphenbutazone was studied by means of equilibrium-dialysis experiments, which were carried out as described previously (Wilting et al., 1980a) . Free concentration of the ligand was determined by liquid-scintillation counting (PackardTri-Carb liquid-scintillation spectrometer, model 2425).
The dialysis experiments were performed by using 6.0 x 10-M-albumin solutions and a drug-to-protein ratio (rD) of 0.3 at 25 'C. The results of the dialysis experiments were used to calculate the molar ellipticity of the ligand-albumin complexes.
C.d. experiments were performed as described previously (Wilting et al., 1980b The pH-stat experiments were carried out with the apparatus described by Janssen & Van Wilgenburg (1978) . Oleic acid was added stepwise to an albumin solution with a fixed pH. Each time the oleic acid was added, the pH of the albumin solution was subsequently titrated back to its original value. The difference between the protonic charge of the albumin in the presence and in the absence of oleic acid (AZ3) can be calculated (Janssen et al., 1970; Janssen & Van Wilgenburg, 1978) from the amount of KOH or HCI needed to bring the pH back to its original value. The pH-stat experiments were done at 25°C.
The experiments were carried out at pH 6.4 or at pH 9.2, since at these pH values the albumin exists mainly in one conformational state (N at pH 6.4 and B at pH 9.2).
RESULTS AND DISCUSSION pH-stat experiments
The difference between the protonic charge of the albumin in the presence and in the absence of oleic acid (AZ3) was measured by using a pH-stat technique. Positive AZ3 values indicate that the pK values in protein and/or fatty acid shift to higher values when oleic acid is added, whereas negative AZ3 values indicate a shift to lower values (Janssen et al., 1970; Janssen & Van Wilgenburg, 1978; Droge et al., 1983) . Fig. 1 shows the relation between AZ3 and the molar ratio of oleic acid to albumin (rF) at pH 6.4 and 9.2. By using the binding parameters for the binding of oleic acid to albumin calculated by Goodman (1958) , it can be demonstrated that, between rF = 0 and rF = 9, the value of rF is approximately equal, within 10 %, to the number of oleic acid molecules bound to one albumin molecule (VF). This means that Fig. 1 can also be seen as the relationship between AZ3 and VF. This Figure shows that AZ3 varies considerably with rF. Moreover, there is a remarkable difference between the AZ3-versus-rF relationships at pH 6.4 and 9.2.
As was stated above, AZ3 is related to pK changes in the protein and/or the ligand. If the negatively charged carboxy group of oleic acid interacts with some positively charged groups of albumin, it is reasonable to assume that, when oleic acid binds to albumin, the pK of oleic acid will decrease and the pK of any amino acid residue in the albumin will increase. Since the pK of oleic acid is 4.8 (Simpson et al., 1974) , such a pK shift in oleic acid will not be apparent in the AZ3-versus-rF relationship at pH 9.2 and will make only a negligible contribution to the AZ3-versus-rF relationship at pH 6.4. Therefore AZ3 as given in Fig. 1 (Spector, 1975) that the e-amino groups of lysine residues are involved in the electrostatic part of the interaction between fatty acid anions and albumin. Since these amino acid residues have pK values of about 10, increases in the pK of lysine side chains would have too small an effect on the uptake of protons to explain the observed AZ3 values. However, in addition to causing pK shifts due to salt-bridge formation between the ligand and the albumin, the ligand can also cause pK shifts in the albumin by changing its conformation. Depending on the pH, albumin will be in either the N or the B conformation (Leonard et al., 1963; Harmsen et al., 1971; Wilting et al., 1980a) . Since the pK of some histidine residues in the N conformation is higher than the pKof those in the B conformation (Harmsen et al., 1971 ; Janssen et al., 1981; Droge et al., 1983) , an oleic acid-induced shift of the N-B transition should lead to pK shifts. For instance, the negative value of AZ3 at pH 6.4 can be explained by assuming that, owing to the presence of oleic acid, a larger fraction of albumin occurs in the B conformation. However, in order to explain the positive value of AZ3 observed at pH 9.2, one has to assume that the albumin has shifted to the N conformation. If this is the mechanism involved here, it is still difficult to explain the large -positive pK shifts at pH 6.4 when rF values are larger than 7.
Another striking feature of Fig. 1 is that both at pH 6.4 and at pH 9.2 the AZ3-versus-rF relationship can be split up into three parts at about rF = 2 and rF = 7. It is striking that this classification is very similar to the classification given by Goodman (1958) , namely two high-affinity sites, five medium-affinity sites and about 20 low-affinity sites. C.d. experiments Fig. 2 Goodman (1958) .
On the basis of these findings we can now try and explain the profiles observed in Fig. 2 . The most simple Vol. 250 [6] . Since Ashbrook et al. (1975) proved that the binding of oleic acid to albumin does not have a co-operative character, the latter assumption is probably more correct. With help of the data for the interaction of oleic acid with albumin obtained by Goodman (1958) , we calculated v1, V2 and v3 for every rF value. Because of the rF independence of, [6] at vE > 9, a value of 2-was chosen for V3. The four experimental curves of Fig. 2 were then fitted to the equation. It can be seen from this Figure  that , at both pH 6.4 and 9.2, the fits made according to eqn. (3) are remarkably good, especially for the diazepam-albumin complex. The fits for the oxyphenbutazone-albumin complex are somewhat less satisfactory. If the medium-affinity sites of oleic acid are split up, the fits for the oxyphenbutazone-albumin complex at pH 6.4 and at pH 9.2 improve considerably. This means that there might be more than three N and B conformations.
The combined data obtained by means of a pH-stat technique and c.d. experiments point to the existence of oleic acid-induced conformational changes in albumin. The conformational changes observed by these methods are probably the same as those recently described as 'N* ' and 'B*' (Wanwimolruk & Birkett, 1982; Droge et al., 1985) . The existence of these conformational changes was deduced from experiments which are described by step 2 in Scheme 1; the experiments discussed here, however, are based on step 3 in Scheme 1. The present results also suggest that the course of these N-N* and B-B* transitions is determined by the classification of the oleic acid-binding sites proposed by Goodman (1958) .
